Kobayashi Pharmaceutical Co Ltd

Common Name
Kobayashi Pharmaceutical
Country
Japan
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
3,615
Ticker
4967
Exchange
TOKYO STOCK EXCHANGE
Description
Kobayashi Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in developing, manufacturing, and selling consumer health products. The company's portfolio includ...

Disclosures of Kobayashi Pharmaceutical

Explore Kobayashi Pharmaceutical's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Kobayashi Pharmaceutical's official channels and fully traceable to its official company sources.

The table below lists all of Kobayashi Pharmaceutical's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Financial resultsN/A
Corporate Governance ReportN/A
Notification regarding own sharesN/A
Financial resultsN/A
Share buyback reportN/A
Notification regarding own sharesN/A
Integrated Report2025
Quarterly securities report2023
Quarterly securities report2023
ESG Data Spreadsheet2023
Integrated Report2022
Integrated Report2021
Integrated Report2020
Integrated Report2019
Integrated Report2018
Integrated Report2017
Annual Report2016
Annual Report2016
Annual Report2015
Annual Report2013
Annual Report2011
Annual Report2010
Annual Report2009
Annual Report2008
Annual Report2007
Annual Report2005
Annual Report2004
Annual Report2003
Annual Report2002
Annual Report2001
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?